Sort
21,281 grants matching “influenza”
Using Dendrimers to Design Multivalent Therapeutic Agents
$292,990Mary J Cloninger · Montana State University - Bozeman · R01 · FY2014 · GM
Genetically-Programmed APC Vaccines Against Viruses
$292,988Maurizio Zanetti · University Of California, San Diego · R01 · FY2007 · AI
Clinical Core
$292,944Donna L Farber · Columbia University Health Sciences · U19 · FY2022 · AI
Single Cell Core
$292,944Peter Alan Sims · Columbia University Health Sciences · U19 · FY2022 · AI
Human T cell-mediated immunity to viruses in tissues and circulation
$292,943Donna L Farber · Columbia University Health Sciences · U19 · FY2022 · AI
Targeted in vivo perturbation for dissecting tissue immune responses
$292,943Philip L De Jager · Columbia University Health Sciences · U19 · FY2022 · AI
Human dendritic cell localization and anti-viral function in tissue sites
$292,943Boris Reizis · Columbia University Health Sciences · U19 · FY2022 · AI
Immunoassay and Imaging Core
$292,943Stuart P Weisberg · Columbia University Health Sciences · U19 · FY2022 · AI
Prospective Studies of Avian Influenza Transmission in Asia
$292,940Gregory Charles Gray · University Of Iowa · R01 · FY2007 · AI
MOLECULAR MECHANISMS OF VIRAL MEMBRANE FUSION PROTEINS
$292,940University Of Virginia Charlottesville · R01 · FY2000 · AI
Statistical Methods in HIV Vaccine Efficacy Trials
$292,871Peter B. Gilbert · Fred Hutchinson Cancer Research Center · R37 · FY2013 · AI
Prime/Boost Immunization against HIV-1 by Viral Vectors
$292,865Thomas Jefferson University · R21 · FY2003 · AI
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination
$292,855Mark M Davis · Stanford University · U19 · FY2015 · AI
UP REGULATION OF MUCIN GENE TRANSCRIPTION--OTITIS MEDIA
$292,853House Ear Institute · R01 · FY2002 · DC
Targets and mechanism of a radical SAM enzyme involved in the cellular antiviral response
$292,817E Neil Marsh · University Of Michigan At Ann Arbor · R01 · FY2015 · GM
Phase 1 Clinical Trial to Assess the Pharmacokinetics, Safety and Tolerance of a Zanamivir Transdermal System in Healthy Subjects
$292,746Elke Lipka · Tsrl, Inc. · U44 · FY2024 · AI
Simulations of Proton Translocation in Biomolecules
$292,664Gregory A. Voth · University Of Chicago · R01 · FY2010 · GM
Targets and mechanism of a radical SAM enzyme involved in the cellular antiviral response
$292,534E Neil Marsh · University Of Michigan At Ann Arbor · R01 · FY2016 · GM
Genetic and Environmental Factors in the Response to Influenza Vaccination
$292,517William H Robinson · Stanford University · U19 · FY2015 · AI
Genomics Core
$292,513Stephen R Quake · Stanford University · U19 · FY2015 · AI
Co-encapsulation of IroN and IL-12 as an Extra-intestinal E. coli Vaccine.
$292,501Thomas F Conway · Therapyx, Inc. · R43 · FY2008 · AI
Reproducible Analytics for Secondary Analyses of ImmPort Vaccination-Related Cytometry Data
$292,500Yu Qian · J. Craig Venter Institute, Inc. · UH2 · FY2019 · AI
The role of MMP activity in T cells during influenza virus pathogenesis
$292,500Bas Baaten · Sidney Kimmel Cancer Center · R21 · FY2008 · AI
Defining the role of lymphotoxin signaling in viral-induced lung immunopathology
$292,500Alexei V Tumanov · Trudeau Institute, Inc. · R21 · FY2015 · AI
CONTROL OF EPIDEMIC INFLUENZA
$292,495Baylor College Of Medicine · U01 · FY2002 · AI